Search research articles
Contact Us
Filters
Showing results (641-650 of 703) with videos related to
Page
of 71
Sort By:
Scientific Reports
|
November 10, 2018
FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
Rowan F van Golen, Pim B Olthof, Daniël A Lionarons, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2016
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis
Serge J Zweers, Alexey Shiryaev, Mina Komuta, et al.
Nature
|
April 15, 2026
Prospective evaluation of genomics-guided off-label treatment
K Verkerk, A C Spiekman, S F Haj Mohammad, et al.
Ebiomedicine
|
March 19, 2025
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours
Chiel F Ebbelaar, Anne M L Jansen, Leonie C M Speet, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 4, 2020
Longitudinal associations of light-intensity physical activity with quality of life, functioning and fatigue after colorectal cancer
E H van Roekel, J Duchâteau, M J L Bours, et al.
Seminars in Arthritis and Rheumatism
|
June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition disease
Nicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Gastroenterology
|
May 15, 2018
Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2
Sanne W Ten Broeke, Tom C van Bavel, Anne M L Jansen, et al.
Nature Communications
|
May 6, 2015
Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis
Jurgen van Heemst, Diahann T S L Jansen, Savvas Polydorides, et al.
ESMO Open
|
January 8, 2025
The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP)
K Verkerk, L J Zeverijn, J van de Haar, et al.
Plos One
|
January 26, 2016
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets
Humaira Rasheed, Cushla McKinney, Lisa K Stamp, et al.
Page
of 71
Search research articles
Search
Showing results (641-650 of 703) with videos related to
Sort By:
Page
of 71
Scientific Reports
|
November 10, 2018
FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis
Rowan F van Golen, Pim B Olthof, Daniël A Lionarons, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2016
Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis
Serge J Zweers, Alexey Shiryaev, Mina Komuta, et al.
Nature
|
April 15, 2026
Prospective evaluation of genomics-guided off-label treatment
K Verkerk, A C Spiekman, S F Haj Mohammad, et al.
Ebiomedicine
|
March 19, 2025
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours
Chiel F Ebbelaar, Anne M L Jansen, Leonie C M Speet, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
July 4, 2020
Longitudinal associations of light-intensity physical activity with quality of life, functioning and fatigue after colorectal cancer
E H van Roekel, J Duchâteau, M J L Bours, et al.
Seminars in Arthritis and Rheumatism
|
June 12, 2026
The OMERACT core domain sets for calcium pyrophosphate deposition disease
Nicola Dalbeth, Yiling Zhang, Owen Hensey, et al.
Gastroenterology
|
May 15, 2018
Molecular Background of Colorectal Tumors From Patients With Lynch Syndrome Associated With Germline Variants in PMS2
Sanne W Ten Broeke, Tom C van Bavel, Anne M L Jansen, et al.
Nature Communications
|
May 6, 2015
Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis
Jurgen van Heemst, Diahann T S L Jansen, Savvas Polydorides, et al.
ESMO Open
|
January 8, 2025
The pathway alteration load is a pan-cancer determinant of outcome of targeted therapies: results from the Drug Rediscovery Protocol (DRUP)
K Verkerk, L J Zeverijn, J van de Haar, et al.
Plos One
|
January 26, 2016
The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets
Humaira Rasheed, Cushla McKinney, Lisa K Stamp, et al.
Page
of 71